Nima Farzan

Insider Reports History

Location
Lexington, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nima Farzan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. Director Common Stock 5.25K $75.8K $14.44 04 Jun 2025 Direct
Kinnate Biopharma Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 0 $0 $2.59 03 Apr 2024 Direct
Keros Therapeutics, Inc. Director Stock Option (right to buy) 10.5K 04 Jun 2025 Direct
Kinnate Biopharma Inc. CHIEF EXECUTIVE OFFICER, Director Stock Option (right to buy) 0 03 Apr 2024 Direct

Insider Reports Filed by Nima Farzan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KROS Keros Therapeutics, Inc. 04 Jun 2025 2 $0 4 Director 06 Jun 2025, 16:15
KROS Keros Therapeutics, Inc. 30 May 2024 1 $0 4 Director 03 Jun 2024, 16:15
KNTE Kinnate Biopharma Inc. 03 Apr 2024 6 $0 4 CHIEF EXECUTIVE OFFICER, Director 05 Apr 2024, 16:55
KROS Keros Therapeutics, Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:38
KNTE Kinnate Biopharma Inc. 10 Feb 2023 1 $0 4/A Chief Executive Officer, Director 15 Feb 2023, 10:01
KROS Keros Therapeutics, Inc. 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:24
KNTE Kinnate Biopharma Inc. 11 Feb 2022 1 $0 4 Chief Executive Officer, Director 15 Feb 2022, 15:00
KROS Keros Therapeutics, Inc. 01 Jun 2021 1 $0 4 Director 03 Jun 2021, 17:29